0001209191-22-043994.txt : 20220802
0001209191-22-043994.hdr.sgml : 20220802
20220802191641
ACCESSION NUMBER: 0001209191-22-043994
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220802
FILED AS OF DATE: 20220802
DATE AS OF CHANGE: 20220802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blunt Roshawn A.
CENTRAL INDEX KEY: 0001787773
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 221130502
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL STE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-02
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001787773
Blunt Roshawn A.
C/O RENEO PHARMACEUTICALS, INC.
18575 JAMBOREE ROAD, SUITE 275-S
IRVINE
CA
92612
1
0
0
0
Stock Option (right to buy)
2.80
2022-08-02
4
A
0
35000
0.00
A
2032-08-01
Common Stock
35000
35000
D
The shares subject to the stock option vest and become exercisable in equal monthly installments over a three-year period.
/s/ Jennifer Lam, Attorney-in-Fact
2022-08-02